13.78
price down icon1.78%   -0.25
after-market Dopo l'orario di chiusura: 14.05 0.27 +1.96%
loading

Novocure Ltd Borsa (NVCR) Ultime notizie

pulisher
08:35 AM

New TTFields Data Presentations Might Change The Case For Investing In NovoCure (NVCR) - simplywall.st

08:35 AM
pulisher
10:27 AM

How NovoCure Limited stock benefits from global expansionWeekly Stock Summary & Weekly Watchlist of Top Performers - Trung tâm Dự báo KTTV quốc gia

10:27 AM
pulisher
Oct 16, 2025

NovoCure Ltd. Hits Day High with Strong 7.67% Intraday Surge - Markets Mojo

Oct 16, 2025
pulisher
Oct 16, 2025

Why NovoCure Limited stock is rated strong buyAnalyst Downgrade & Daily Price Action Insights - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

NovoCure Limited stock volume spike explainedWeekly Stock Recap & Weekly Return Optimization Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Novocure to present tumor treating fields data at upcoming oncology congresses - Investing.com Australia

Oct 15, 2025
pulisher
Oct 15, 2025

Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress - Yahoo Finance

Oct 15, 2025
pulisher
Oct 15, 2025

Tumor Treating Fields Market Demand, Growth, and Future Scope (2025-2032) Featuring Novocure GmbH and Zai Lab - openPR.com

Oct 15, 2025
pulisher
Oct 15, 2025

How to manage a losing position in NovoCure LimitedStop Loss & Momentum Based Trading Signals - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Is NovoCure Limited stock ready for a breakoutWeekly Trend Report & High Conviction Buy Zone Picks - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

What sentiment indicators say about NovoCure Limited stockTrade Risk Assessment & Daily Volume Surge Signals - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Should you wait for a breakout in NovoCure LimitedPortfolio Performance Summary & Stepwise Trade Execution Plans - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

NovoCure (NVCR): Evaluating Valuation as METIS Phase 3 Brain Metastases Results Reach Industry Conference Milestone - simplywall.st

Oct 12, 2025
pulisher
Oct 10, 2025

Using data tools to time your NovoCure Limited exitJuly 2025 Trends & Target Return Focused Stock Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

NovoCure's (NVCR) Sell (E+) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Final METIS Trial Results for TTFields Therapy Could Be a Game Changer for NovoCure (NVCR) - Sahm

Oct 10, 2025
pulisher
Oct 10, 2025

Should I buy NovoCure Limited (038) stock before earnings seasonJuly 2025 Short Interest & Accurate Buy Signal Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why NovoCure Limited (038) stock remains top ratedEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

NovoCure Ltd. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 09, 2025
pulisher
Oct 08, 2025

NovoCure (NASDAQ:NVCR) vs. Evogene (NASDAQ:EVGN) Head-To-Head Analysis - Defense World

Oct 08, 2025
pulisher
Oct 07, 2025

NovoCure Limited (NVCR) Stock Analysis: A Closer Look at an 87.5% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews

Oct 07, 2025
pulisher
Oct 07, 2025

NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of “Hold” by Analysts - Defense World

Oct 07, 2025
pulisher
Oct 07, 2025

Evercore Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $25 - 富途牛牛

Oct 07, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 04:02:03 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Analyzing NovoCure Limited with multi timeframe chartsQuarterly Trade Report & Low Volatility Stock Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

NovoCure (NVCR): Assessing Valuation After Positive Phase 3 METIS Trial Results Unveiled - simplywall.st

Oct 04, 2025
pulisher
Oct 03, 2025

Volume spikes in NovoCure Limited stock – what they mean2025 Support & Resistance & Capital Protection Trading Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will NovoCure Limited (038) stock keep high P E multiplesRecession Risk & Safe Entry Trade Signal Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Why NovoCure (NVCR) Is Up 9.9% After Phase 3 METIS Trial Success in Brain Metastases - simplywall.st

Oct 03, 2025
pulisher
Oct 02, 2025

How NovoCure Limited (038) stock responds to job market shiftsJuly 2025 Outlook & Short-Term High Return Strategies - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Medical Technology Firm Novocure Schedules Q3 2025 Financial Results with Investor Conference Call - Stock Titan

Oct 01, 2025
pulisher
Oct 01, 2025

Novocure to Report Third Quarter 2025 Financial Results - The Globe and Mail

Oct 01, 2025
pulisher
Oct 01, 2025

Why NovoCure Limited is moving todayQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

NovoCure stock rating reiterated at Buy by H.C. Wainwright on METIS trial data - Investing.com Nigeria

Sep 30, 2025
pulisher
Sep 30, 2025

NovoCure's (NVCR) "Neutral" Rating Reaffirmed at Wedbush - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

Pattern recognition hints at NovoCure Limited upsideTrade Volume Report & Real-Time Chart Breakout Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Novocure (NVCR) Announces Positive Phase 3 METIS Trial Results - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Novocure’s cancer therapy delays brain metastases progression By Investing.com - Investing.com Australia

Sep 29, 2025
pulisher
Sep 29, 2025

Novocure’s cancer therapy delays brain metastases progression - Investing.com India

Sep 29, 2025
pulisher
Sep 29, 2025

15-Month Brain Metastases Control: Novocure's TTFields Therapy Shows Breakthrough in Lung Cancer Trial - Stock Titan

Sep 29, 2025
pulisher
Sep 29, 2025

Live market analysis of NovoCure LimitedJuly 2025 Selloffs & Safe Entry Point Identification - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Washington Capital Management Inc. Invests $374,000 in NovoCure Limited $NVCR - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

How NovoCure Limited stock benefits from strong dollarJuly 2025 Patterns & Risk Controlled Swing Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Regression analysis insights on NovoCure Limited performancePortfolio Risk Report & Fast Gain Swing Alerts - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-28 23:33:37 - newser.com

Sep 29, 2025
pulisher
Sep 27, 2025

NovoCure Limited stock outlook for YEARJuly 2025 Intraday Action & Fast Gain Stock Tips - newser.com

Sep 27, 2025
pulisher
Sep 26, 2025

Is NovoCure Limited (038) stock a buy on weaknessJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com

Sep 26, 2025
$318.59
price up icon 0.73%
medical_devices STE
$240.21
price down icon 0.04%
$66.60
price up icon 0.41%
medical_devices PHG
$28.52
price up icon 0.67%
$74.05
price up icon 0.91%
medical_devices EW
$74.64
price up icon 2.74%
Capitalizzazione:     |  Volume (24 ore):